← Back to Search

Ultrasound Therapy

Focused Ultrasound for ADHD

N/A
Waitlist Available
Led By Sheldon Jordan, MD
Research Sponsored by Neurological Associates of West Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
Diagnosis of Attention Deficit Hyperactive Disorder (ADHD)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post final treatment (8 weeks from baseline)
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will study the long-term effects of transcranial ultrasound on people with ADHD.

Who is the study for?
Adults diagnosed with ADHD who haven't had success with standard treatments like stimulants or therapy can join. They must score at least 8 on the ASRS-V1.1 questionnaire for ADHD symptoms and be able to give informed consent. People with recent surgery, pregnancy, severe organ failure, cancer, macular degeneration, scalp conditions, or inability to remain still are excluded.Check my eligibility
What is being tested?
The trial is testing the Brainsonix Pulsar 1002 device's safety and potential effectiveness in treating ADHD symptoms over a longer period. It's an open label study where everyone knows they're getting the treatment being tested.See study design
What are the potential side effects?
Potential side effects of transcranial ultrasound treatment may include discomfort at the site of application or headaches due to sound waves affecting brain tissue; however specific side effects will be monitored throughout the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with ADHD.
Select...
Standard treatments like medication or therapy haven’t improved my symptoms.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post final treatment (8 weeks from baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post final treatment (8 weeks from baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Adult ADHD Self-Report Scale (ASRS-v1.1)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Focused UltrasoundExperimental Treatment1 Intervention
On the day of the ultrasound appointment, patients will undergo ten minutes of ultrasound targeting the anterior cingulate. The DWL Doppler ultrasound device enables visual and auditory waveform confirmation of the anterior cerebral artery, and optical tracking technology (e.g., AntNeuro Visor2™ system) may be used in tandem with the Brainsonix ultrasound device to track a patient's brain in virtual space as well as their physical location, thereby ensuring accurate placement.

Find a Location

Who is running the clinical trial?

Neurological Associates of West Los AngelesLead Sponsor
25 Previous Clinical Trials
3,860 Total Patients Enrolled
Sheldon Jordan, MDPrincipal InvestigatorNeurological Associates of West Los Angeles
12 Previous Clinical Trials
2,490 Total Patients Enrolled

Media Library

Brainsonix Pulsar 1002 (Ultrasound Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04497363 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Focused Ultrasound
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Brainsonix Pulsar 1002 Highlights & Side Effects. Trial Name: NCT04497363 — N/A
Brainsonix Pulsar 1002 (Ultrasound Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04497363 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT04497363 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase of this medical experiment still ongoing?

"Per the clinicaltrials.gov database, this research is not currently recruiting patients; however it was initially advertised on July 1st 2020 and most recently edited September 26th 2022. At present there are 137 different trials hunting for participants."

Answered by AI

What criteria must potential participants meet to be included in this research?

"This medical research is looking for 100 subjects, aged 18 to 60 years old, that present with attention deficit hyperactivity disorder (ADHD). In addition to this diagnosis, potential candidates must also register a score of 8 or higher on the Adult ADHD Self-Report Questionnaire (ASRS-V1.1), demonstrate an unresponsiveness to traditional symptom management techniques such as stimulants and cognitive behavioural therapy, and be over the age of majority."

Answered by AI

Does this trial accept volunteers of thirty years or older?

"The criteria for this medical trial stipulates that the minimum age of entry is 18, while the upper limit is set at 60 years old."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
Illinois
Other
California
How old are they?
18 - 65
What site did they apply to?
Neurological Associates of West Los Angele
Neurological Associates of West LA
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+
0
2

Why did patients apply to this trial?

I w t help a d money. Finding solutions to innattentive adhd. Im hoping this clinical trial will aid my fight against severe ADHD.
PatientReceived 2+ prior treatments
Executive function difficulties impact my daily life, and I have not found relief through traditional modalities.
PatientReceived no prior treatments
I have tried several medications before in the past. Some work while others did not. I am interested in being able to tackle this deficit in order to be more productive and happy.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

What would exclude me? How will the trial go about? I live in TN but am interested in traveling for the trial. For those who travel, are the room and board, travel costs, etc. compensated by the trial or would I be responsible for everything myself?
PatientReceived no prior treatments
~32 spots leftby Oct 2025